Back to Homepage

How We Acquired 612 Treatment Admissions at 41% Below the Client’s Cost Target

Running a four-state addiction treatment ad program measured on admitted patients, month after month, market by market

Every treatment provider has a number in mind for what a new patient can cost to acquire. Most agencies never learn what that number is.

Our client, a multi-state addiction treatment provider with adult inpatient and outpatient programs across four states, told us theirs on day one: under $3,000 per admission. Not per lead. Not per form fill. Per admitted patient, verified against their own intake records.

In the first six months of 2026, we delivered admissions at $1,761 each. That is 41% below the target, sustained across four markets, two levels of care, and more than a million dollars of managed spend.

Table of Contents

At a glance

  • 612 digital-attributed admissions in six months on $1.08M in managed digital spend
  • $1,761 blended cost per admission against the client’s $3,000 target, beating goal by 41%
  • 23 of 24 market-months came in under the $3,000 target, across four states
  • Outpatient admissions acquired for as little as $381, with multiple markets sustaining outpatient acquisition under $700
  • Digital drives up to 55% of a market’s total admissions, tracked against all attribution sources
  • One market cut its cost per admission 55% in three months, from $2,426 to $1,101

The standard: admissions, not leads

Paid search in addiction treatment is among the most expensive keyword categories in the country. Clicks run into the teens. Competition includes national advertisers and lead brokers with enormous budgets. A single misallocated month can burn tens of thousands of dollars.

What makes it manageable is refusing to report on anything except the outcome. A form fill is not a patient. A phone call is not a patient. In this program, every dollar of spend is reconciled against the client’s actual admissions, split by market and by level of care, and reported on a weekly cadence.

That discipline produces a number the client’s leadership can act on: what it costs, right now, in any one of its four markets, to put one more person into treatment. Then it lets us prove that number is beating the target.


An account structured by market and level of care

The program covers four state markets, each with its own inpatient and outpatient economics, and each carrying its own budget and cost-per-admission target.

That separation matters because inpatient and outpatient admissions are worth very different amounts and behave very differently in the auction. Inpatient searches are lower volume and far more competitive. Outpatient searches are more plentiful and convert more cheaply. Blending them into a single efficiency number would hide both the wins and the problems.

Reported separately, the picture is sharp. Outpatient acquisition in the strongest markets runs remarkably lean, reaching $381 per admission in one state and holding between $400 and $700 across multiple markets and months. Inpatient acquisition costs more, as expected, and is judged against a target appropriate to what an inpatient admission is worth.

Paid search runs alongside a smaller organic program in each market, with both channels reconciled into one blended cost per admission so the client sees total digital efficiency rather than siloed channel metrics.


The results: under target, nearly every month, in every market

Across the first half of 2026:

  • January: 107 admissions. The strongest market acquired admissions at $1,095, with 55% of that market’s total admissions that month attributable to digital
  • February: 115 admissions, the strongest volume month of the period, with three of four markets under $1,900 per admission
  • March through May: volume held between 96 and 100 admissions per month while the program absorbed rising auction costs, with every single market staying under the $3,000 target
  • June: 102 admissions, with three of four markets posting their best or near-best efficiency of the year, at $1,101, $1,595, and $1,693 per admission

The June result reflects deliberate reallocation. One market had been running at $2,426 per admission in March. By June that figure was $1,101, a 55% improvement, achieved by shifting budget toward the campaigns and levels of care that were actually converting to admissions rather than to inquiries.

Across the whole six-month period, 23 of 24 market-months finished under the client’s $3,000 ceiling. The program’s blended cost per admission never exceeded $2,100 in any month, and finished the half at $1,761.


Why this model works

Three habits produce these numbers, and none of them are clever bidding tricks.

Report the outcome, not the proxy. When the scoreboard is admissions, budget naturally flows toward what produces patients. When the scoreboard is conversions, budget flows toward whatever is cheapest to count, which is rarely the same thing.

Separate what behaves differently. Four markets and two levels of care means eight distinct sets of economics. Managing them as one blended account would let strong markets subsidize weak ones invisibly, and would make a problem like that one market’s spring inefficiency impossible to spot, let alone fix in a quarter.

Reconcile weekly, adjust monthly. Weekly reporting against real admissions is what turned that market around inside of three months. A quarterly review would have caught it a quarter too late.

Good to Know

FAQs About Paid Media for Multi-Location Treatment Providers

Why measure cost per admission instead of cost per lead?

Because a lead is not revenue. In treatment, the gap between an inquiry and an admission includes intake staff, insurance verification, and clinical assessment. Two campaigns with identical cost per lead can differ enormously in admissions produced. Reconciling spend against actual admissions is the only way to know which one deserves the budget.

What is a realistic cost per admission in addiction treatment?

It depends on the level of care and the market. In this program, outpatient admissions were acquired for as little as $381 while inpatient admissions cost substantially more, reflecting their higher value and a more competitive auction. The blended figure across four states was $1,761 against a $3,000 target. Every provider should set the target from its own economics rather than an industry average.

Should inpatient and outpatient campaigns be measured together?

No. They have different search volumes, different competitive dynamics, and very different values per admission. Reporting them separately is what makes it possible to see that outpatient is running at $500 while inpatient is running at $3,000, and to fund each appropriately instead of chasing a misleading blended average.

How quickly can an underperforming market be turned around?

With weekly outcome reporting, quickly. One market in this program went from $2,426 per admission in March to $1,101 in June, a 55% improvement in three months, because the inefficiency was visible in-month rather than at the end of a quarter.

How much of a treatment provider’s admissions should come from digital?

It varies by market maturity and referral mix. In this program, digital accounted for between 10% and 55% of total admissions depending on the market and month, measured against all attribution sources including referrals and direct inquiries. Knowing that share is what lets a provider decide where the next marketing dollar should go.

What reporting cadence does a program like this need?

Weekly for reconciliation and pacing, monthly for budget reallocation. The weekly rhythm is what catches a market drifting off target while there is still time in the month to correct it.

Related Case Studies